The consequences of dry eye: Increased incidence of psychiatric disorders, fibromyalgia and chronic fatigue following diagnosis

News
Article

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 American Academy of Ophthalmology meeting.

Reviewed by Gavin Li, MS.

man experiences chronic fatigue following dry eye diagnosis - Image credit: Adobe Stock/©Prostock-studio

Image credit: Adobe Stock/©Prostock-studio

The consequences of dry eye can extend well past the physical limits of the eyeball, according to Gavin Li, MS. Dry eye significantly increases the risk of developing depression, anxiety, fibromyalgia and chronic fatigue, suggesting that dry eye may serve as an early indicator or cause of psychological distress, he reported. Mr Li, from the Icahn School of Medicine at Mount Sinai, New York, presented the findings of his group1 at the 2024 American Academy of Ophthalmology annual meeting in Chicago.

Although the link between dry eye and psychiatric conditions is well-documented, no longitudinal studies have explored the direction of this relationship. To address this gap in the literature, Mr Li and his colleagues assessed whether a new diagnosis of dry eye increases the risk of developing depression, anxiety, fibromyalgia and chronic fatigue compared to those without dry eye.

They used a US-wide Medicare sample to identify individuals who did not have a history of dry eye, fibromyalgia, chronic fatigue or a psychiatric diagnosis. Individuals who developed dry eye from 2012 to 2015 were identified and matched with a control group without dry eye by age, sex, and race, Mr Li recounted.

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes

The authors identified 18,807 individuals without dry eye and 4,702 with dry eye.

The analysis showed that individuals with dry eye were 1.65 times more likely to develop depression, 1.62 times more likely to develop anxiety, 2.41 times more likely to develop fibromyalgia and 1.5 times more likely to develop chronic fatigue (P < 0.001, P < 0.001, P < 0.001, and P = 0.02, respectively).

The investigators point to aspects of previous studies that support their findings, including a strong negative association between dry eye severity and both quality of life and mental health survey scores.2,3

“Dry eye may be an early indicator or contributing factor to psychological distress, and patients who score above a certain threshold on dry eye surveys, such as the Ocular Surface Disease Index, may benefit from screening for psychiatric comorbidities,” they stated.

References

  1. Li G, Schneider YH, Klawe J, et al. Incidence of Psychiatric Disorders, Fibromyalgia and Chronic Fatigue Following Dry Eye Diagnosis Among Medicare Beneficiaries. Presented at the 2024 American Academy of Ophthalmology annual meeting, Chicago, October 18-21; Session: Cornea-External Diseases – PO272
  2. Ren Y, Tian J, Shi W, et al. Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study. BMC Ophthalmol. 2023;23:229. doi:10.1186/s12886-023-02959-5
  3. Sayegh RR, Yu Y, Farrar JT, et al. Ocular discomfort and quality of life among patients in the Dry Eye Assessment and Management Study. Cornea. 2021;40:869-876. doi:10.1097/ICO.0000000000002580
Recent Videos
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
© 2024 MJH Life Sciences

All rights reserved.